Health Links

You Docs logo
Dr. Mehmet Oz and Dr. Michael Roizen, the YOU Docs, are well-known for their regular appearances on "Oprah" and the Discovery Health Channel and are the authors of the best-sellers "YOU: The Owner's Manual" and "YOU: On a Diet."
--more YOU Docs

All of You - header image
David Quick photo Read
Columnist
David Quick
 

 

Obesity worsens breast cancer prognosis

The following information is provided by a third party and has not been edited by The Post and Courier for content or accuracy.

Friday, December 11, 2009

(Ivanhoe Newswire) -- Breast cancer patients with a high body mass index (BMI) have a poorer cancer prognosis. The effects of their treatment do not last as long, and their risk of dying from the disease is greater.

A healthy, normal BMI score is between 20 and 25. "Overall, women should make an effort to keep their BMI less than 25," Marianne Ewertz, M.D., professor in the Department of Oncology at Odense University Hospital, Denmark, was quoted as saying. "Those who have a high BMI should be encouraged to participate in mammography screening programs for prevention efforts."

Ewertz and colleagues examined the influence of obesity on breast cancer recurrence and mortality in relation to adjuvant treatment. Using the Danish Breast Cancer Cooperative Group database, they evaluated health information such as status at diagnosis, tumor size, malignancy grade, number of lymph nodes removed, estrogen receptor status and treatment regimen from almost 54,000 women. They were able to calculate BMI for 35 percent of the women.

After 30 years of follow-up, from 1977 through 2006, the researchers found that women with higher BMIs had more advanced disease at diagnosis compared with those who had a BMI within the normal range. The risk of distant metastases also increased with a higher BMI.

Women with a high BMI had an increased risk of dying from breast cancer, a finding that remained constant over the study period. Further, adjuvant treatment seemed to lose its effect more rapidly in obese patients, according to Ewertz, who concluded, "More research is needed into the mechanisms behind the poorer response to adjuvant treatment among obese women with breast cancer."

SOURCE: Presented at the CTRC-AACR Annual San Antonio Breast Cancer Symposium, December 9-13, 2009

Share this story:
E-mail this story E-mail this story  Printer-friendly version Printer-friendly version  

Copy and paste the link:

Add this

Comments

Use the comment form below to begin a discussion about this content.

Notice about comments:

Postandcourier.com is pleased to offer readers the enhanced ability to comment on stories. We expect our readers to engage in lively, yet civil discourse. Postandcourier.com does not edit user submitted statements and we cannot promise that readers will not occasionally find offensive or inaccurate comments posted in the comments area. Responsibility for the statements posted lies with the person submitting the comment, not postandcourier.com. If you find a comment that is objectionable, please click "report abuse" and we will review it for possible removal. Please be reminded, however, that in accordance with our Terms of Use and federal law, we are under no obligation to remove any third party comments posted on our website. Read our full Terms and Conditions.

Users can now build user-to-user connections, follow friends' recent posts, add an avatar that fits their personality, and more. If you have posted here before you'll need to sign up again, or if you've never posted before, start now by signing up!



 
 
View a list of area fitness events.